CNS Pharmaceuticals Announces Appointment of Dr. Patrick Wen, Director of Center for Neuro-Oncology at Dana-Farber Cancer Institute, to Science Advisory Board Aug 27, 2020 8:00am EDT
CNS Pharmaceuticals to Provide Second Quarter 2020 Business Update on Thursday, August 13, 2020 Aug 11, 2020 8:00am EDT
CNS Pharmaceuticals Completes Drug Product Manufacturing Strategy for Berubicin Jul 15, 2020 8:00am EDT
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin Jun 11, 2020 8:00am EDT
